LOVD - Variant listings for BRCA2

Patient data (#0000356)
Disease -
Reference United States:Salt Lake City
Template DNA
Technique SEQ
Remarks -
# Reported 1
Submitter Sean V. Tavtigian

Variant data
Allele Unknown
Reported pathogenicity Unknown
Concluded pathogenicity Unknown
Exon 2
DNA change c.3G>A
BIC DNA change 231G>A
Protein change p.M1I
Posterior P 0.981
IARC Class 4 - Likely pathogenic
Key Observational Reference Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23.
Prior P reference Vallee MP et al., Human Mutation 37: 627-639, 2016
Missense analysis Prior P -
Splicing prior P 0.02
Other Prior P 0.00
Combined prior P 0.96
Segregation LR 2.0
Pathology LR -
Sum Family LR -
Co-occurrence LR 1.07
case-control LR -
Product of LRs 2.14
Comments Translation initiation methionine site

1 entry in BRCA2

Path. Allele
Exon Descending
Ascending
DNA change Descending
Ascending
BIC DNA change Descending
Ascending
Protein change Descending
Ascending
Posterior P Descending
Ascending
IARC Class Descending
Ascending
Key Observational Reference Descending
Ascending
Prior P reference Descending
Ascending
Missense analysis Prior P Descending
Ascending
Splicing prior P Descending
Ascending
Other Prior P Descending
Ascending
Combined prior P Descending
Ascending
Segregation LR Descending
Ascending
Pathology LR Descending
Ascending
Sum Family LR Descending
Ascending
Co-occurrence LR Descending
Ascending
case-control LR Descending
Ascending
Product of LRs Descending
Ascending
Comments Descending
Ascending
?/? Unknown 2 c.3G>A 231G>A p.M1I 0.981 4 - Likely pathogenic Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23. Vallee MP et al., Human Mutation 37: 627-639, 2016 - 0.02 0.00 0.96 2.0 - - 1.07 - 2.14 Translation initiation methionine site